Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?

Infection · 2022 · PMC8989116 · PMID 35391649

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This research demonstrated a robust vaccine response with a highly significant increase level of RBD S-protein IgGin subjects with prior SARS-CoV-2 infection compared to previously uninfected individuals at 45 days after the second dose administration of BNT162b2/Pfizer vaccine [ 6 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.